“Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients With Primary Axillary Hyperhydrosis”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S40. https://doi.org/10.25251/skin.2.supp.40.